Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00599209 · ClinicalTrials.gov registry record · NA

Health Information Technology in the Nursing Home

A NA study of Patient Safety and Prescribing Practices, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT00599209: Completed NA study of Patient Safety and Prescribing Practices, sponsored by University of Massachusetts, Worcester.

NCT00599209 is a NA study of Patient Safety and Prescribing Practices that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 23 participants, below the 1,566-participant average among 6 other Patient Safety trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00599209, a NA study of Patient Safety and Prescribing Practices, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The magnitude and intensity of medication use among our nation's 1.6 million nursing home residents matches or exceeds that of hospitalized patients. The residents of nursing homes are among the most frail patients in the population; the challenges of using medications in this setting are great, not only because of the physiologic declines and pharmacologic changes that occur with aging, but also because of the special clinical and social circumstances that often characterize nursing home care. In our previous research, we have determined that medication errors resulting in adverse drug events occur most often at the ordering and monitoring stages of pharmaceutical care. Clinical decision-support systems are clinical consultation systems that combine individual patient information with population statistics and scientific evidence to offer real-time information to health care providers. These systems have been found to improve the quality of medication prescribing in the hospital setting. In this study, we intend to determine the extent to which a computer-based clinical decision-support system (accompanying computerized provider order-entry) can improve the quality of medication ordering and monitoring for residents in the long-term care setting through a randomized trial. We will track the costs associated with this system and the system's impact on the productivity of providers. We will also assess the culture of U.S. nursing homes and the organization of the nursing home setting with respect to readiness to incorporate computerized provider order-entry with computer-based clinical decision support. Our project addresses specific areas that are of particular interest to AHRQ with special relevance to the delivery of high-quality care to a priority population--the frail elderly patient population residing in nursing homes. The project will assess the economic implications of health information technology in the nursing home environment that will be of interest to

Interventions

  • OTHER clinical decision support

Study Locations (1)

Massachusetts

  • Meyers Primary Care Institute - Worcester

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2004-09
Est. Completion 2008-09
Phase NA

What the finished NCT00599209 record still lists

NCT00599209 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,566-participant average among 6 other Patient Safety trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Patient Safety appearing as the primary indexed condition, and to 1 intervention - of which clinical decision support is the first listed.

NCT00599209 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00599209 about?

NCT00599209 is a clinical study titled "Health Information Technology in the Nursing Home". The magnitude and intensity of medication use among our nation's 1.6 million nursing home residents matches or exceeds that of hospitalized patients. The residents of nursing homes are among the most frail patients in the population; the challenges of using medications in this setting are great, not...

What is the current status of trial NCT00599209?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2004-09. Estimated completion is 2008-09.

What conditions does trial NCT00599209 study?

This clinical trial studies the following conditions: Patient Safety, Prescribing Practices, Laboratory Monitoring Practices.

What interventions are being tested in trial NCT00599209?

The interventions under investigation include: clinical decision support (OTHER).

Who is sponsoring clinical trial NCT00599209?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00599209 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Safety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00599209, the US trial registry maintained by the National Library of Medicine. NCT00599209 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.